A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

The $16 billion in disaster aid covers crop losses due to natural disasters from 2023 and 2024. It's the largest chunk of the ...

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...